ARCHIVIO

• Pubblicazioni dal 2003 al 2008

Che cos’è l’impact factor?

L'impact factor é l'indice che misura la frequenza con cui gli articoli di una determinata rivista vengono citati: in pratica una valutazione della rilevanza scientifica di quella rivista. Su alcune migliaia di riviste scientifiche esistenti al mondo, meno di cento hanno un impact factor superiore a 10.

Considerando il numero di articoli pubblicati su Cell e Nature negli ultimi cinque anni, IFOM appare in posizione di netta superiorità rispetto alle altre istituzioni italiane ed in posizione molto competitiva a livello europeo, come evidenziato dai grafici che seguono:

»Campus IFOM-IEO vs Istituti di ricerca italiani

»Campus IFOM-IEO vs Istituti di ricerca europei

»IFOM vs Istituti di ricerca europei

Nel 2009 gli scienziati IFOM hanno pubblicato 123 articoli di ricerca su riviste scientifiche internazionali, con un impact factor medio pari a 7.864 (calcolato sugli articoli pubblicati nelle riviste provviste di impact factor).

Focus

Tra le pubblicazioni del 2009, segnaliamo:

- una ricerca condotta da Marina Mione, il cui risultato è stato pubblicato a febbraio sulla rivista Disease Models & Mechanisms.
La ricerca, condotta sull’organismo modello Zebrafish, individua i meccanismi molecolari che stanno alla base del legame tra il gene Ras (la cui alterazione è individuata nel 20% dei tumori) e la Sindrome di Costello, una malattia genetica che colpisce in età infantile e induce le cellule staminali del cuore e del cervello alla senescenza, accorciando notevolmente la vita degli individui affetti da questa malattia. Le prospettive di questa ricerca sono, oltre alla cura dei malati di sindrome di Costello, lo sviluppo di nuove cure contro i tumori, che sfruttino il meccanismo di senescenza attivato da Ras per bloccare la proliferazione delle cellule tumorali.
La ricerca è stata sostenuta da un finanziamento AIRC.

- Una ricerca condotta da Ugo Cavallaro pubblicata a marzo sulla rivista Journal of Experimental Medicine.
Lo studio individua un ruolo inedito della molecola di adesione neurale L1 nella regolazione del sistema immunitario. Il ruolo di questa molecola era infatti ben noto nello sviluppo cerebrale, ed era stata dimostrata la connessione tra sue mutazioni e la sindrome neurologica CRASH (Corpus callosum genesis, Retardation, Adducted thumbs, Spastic paraplegia, Hydrocephalus). Lo studio di Ugo Cavallaro rivela che la molecola L1 gioca un ruolo chiave anche nel sistema immunitario, aprendo interessanti prospettive terapeutiche contro le metastasi correlate a tumore del colon, melanomi e carcinoma ovarico.
La ricerca è stata sostenuta da un finanziamento AIRC.

- Una ricerca condotta da Marco Foiani pubblicata ad aprile sulla rivista Cell, che ha dedicato allo studio anche la copertina. La ricerca rivela i meccanismi di formazione del tumore nei pazienti affetti da Ataxia-Telangiectasia (AT) e da Ataxia-Telangiectasia Like Disorder (ATLD), patologie ereditarie che predispongono all'insorgenza tumorale. La ricerca apre la strada a metodologie di diagnosi precoce e a cure personalizzate. La ricerca è stata sostenuta da un finanziamento AIRC.

- Una ricerca condotta da Marco Foiani pubblicata a settembre su Cell. Grazie a un approccio sperimentale innovativo la ricerca consente di visualizzare per la prima volta nella sua complessità tridimensionale il processo regolato dalla proteina Top2 per tutelare la stabilità del DNA, difendendo l'organismo dall'insorgenza spontanea di mutazioni e quindi di tumori. La ricerca contribuisce a chiarire le basi molecolari del meccanismo di formazione del cancro e apre la strada allo sviluppo di cure anticancro mirate. La ricerca è stata sostenuta da un finanziamento AIRC.

- Una ricerca condotta da Pier Paolo Di Fiore pubblicata a dicembre sulla rivista PNAS. Lo studio dimostra che più di un terzo dei tumori polmonari presentano un’alterazione funzionale nel gene NOTCH, gene già noto per il suo coinvolgimento nella formazione e nello sviluppo dei tumori e in particolare di alcuni tipi di leucemia. Lo studio del Prof. Di Fiore ha dimostrato il coinvolgimento di questo gene anche nella formazione e nello sviluppo dei tumori solidi che costituiscono il gruppo più frequente di neoplasie umane e ha già individuato la strategia terapeutica per invertire il potenziale di crescita tumorale determinata da NOTCH, utilizzando cellule tumorali isolate da tessuti di pazienti affetti da cancro polmonare. Questo studio apre quindi promettenti prospettive di applicazione clinica per combattere il tumore polmonare, che è la prima causa di morte nei paesi industrializzati. La ricerca è stata sostenuta da un finanziamento AIRC.

Riconoscimenti scientifici

- Da gennaio 2009 Marco Foiani (attuale Direttore Scientifico di IFOM) e Pier Paolo Di Fiore (precedente Direttore Scientifico di IFOM), sono entrati a far parte dell’Editorial Board di Cell.
Foiani e Di Fiore sono gli unici due ricercatori italiani operanti in istituti di ricerca italiani, sui 113 membri dell’Editorial Board della prestigiosa rivista.

- Nel gennaio 2009 è stato assegnato il prestigioso Premio Sapio a Fabrizio D’Adda di Fagagna, group leader di IFOM, per i suoi studi sulla proliferazione cellulare nei tumori e senescenza.
Il Premio Sapio è attribuito ad un ricercatore i cui studi abbiano portato risultati innovativi e determinanti per il miglioramento delle condizioni di vita dell’uomo.

- Nel mese di settembre l’EARC (European Association for Cancer Research) ha assegnato a Fabrizio D’Adda di Fagagna il prestigioso premio Young Cancer Researcher Award. Il premio viene annualmente destinato a un giovane scienziato i cui studi abbiano portato un contributo straordinario nella ricerca di base sul cancro.

- Nel novembre 2009 l’EMBO (European Molecular Biology Organisation) ha inserito la group leader IFOM Simona Polo nel programma EMBO Young Investigator. Si tratta del gruppo di ricercatori europei di maggior talento che EMBO segnala all’attenzione della comunità scientifica internazionale. Simona Polo è l’unica scienziata italiana tra i 17 giovani scienziati selezionati nel 2009.

Elenco delle pubblicazioni IFOM 2009 (in ordine alfabetico per rivista scientifica)

• Raynaud CM, Hernandez J, Llorca FP, Nuciforo P, Mathieu MC, Commo F, Delaloge S, Sabatier L, André F, Soria JC.
  DNA Damage Repair and Telomere Length in Normal Breast, Preneoplastic Lesions, and Invasive Cancer.
  Am J Clin Oncol. 2009,Oct 30. IF: 1,792
• Omodei D, Acampora D, Russo F, De Filippi R, Severino V, Di Francia R, Frigeri F, Mancuso P, De Chiara A, Pinto A, Casola S, Simeone A.
  Expression of the Brain Transcription Factor OTX1 Occurs in a Subset of Normal Germinal-Center B Cells and in Aggressive Non-Hodgkin Lymphoma.
  Am J Pathol. 2009, Dec;175(6); 2609-17. IF: 5,697
• Flonta SE, Arena S, Pisacane A, Michieli P, Bardelli A.
  Expression and functional regulation of myoglobin in epithelial cancers. Am J Pathol. 2009, Jul;175(1); 201-6. IF: 5,697
• Colombo M, Ripamonti CB, Pensotti V, Foglia C, Peissel B, Pierotti MA, Manoukian S, Radice P.
  An unusual BRCA2 allele carrying two splice site mutations.
  Ann Oncol. 2009, Jun;20(6); 1143-4. IF: 4,935
• Stone OA, Richer C, Emanueli C, van Weel V, Quax PH, Katare R, Kraenkel N, Campagnolo P, Barcelos LS, Siragusa M, Sala-Newby GB, Baldessari D, Mione M, Vincent MP, Benest AV, Al Haj Zen A, Gonzalez J, Bates DO, Alhenc-Gelas F, Madeddu P.
  Critical Role of Tissue Kallikrein in Vessel Formation and Maturation. Implications for Therapeutic Revascularization.
  Arterioscler Thromb Vasc Biol. 2009, May;29(5); 657-64. IF: 6,858
• Mensah Nana Yaa, Peterlongo Paolo*, Steinherz Peter, Pamer G. Eric, Satagopan Jaya, Genovefa Anna Papanicolaou
  Toll-Like Receptor 4 Polymorphisms and Risk of Gram-Negative Bacteremia after Allogeneic Stem Cell Transplantation. A Prospective Pilot Study
  Biology of Blood and Marrow Transplantation. 2009, Vol. 15, Issue 9, Pages 1130-1133 NO IF
• Naso A, Dreyer I, Pedemonte L, Testa I, Gomez-Porras JL, Usai C, Mueller-Rueber B, Diaspro A, Gambale F, Picco C.
  The role of the C-terminus for functional heteromerization of the plant channel KDC1.
  Biophys J. 2009, May 20;96(10); 4063-74. IF: 4,683
• Alfano M, Mariani SA, Elia C, Pardi R, Blasi F, Poli G.
  Ligand-engaged urokinase-type plasminogen activator receptor (uPAR) and activation of the CD11b/CD18 (Mac1) integrin inhibit late events of HIV expression in monocytic cells.
  Blood. 2009, Feb 19;113(8); 1699-709. IF: 10,432
• Woodfin A, Voisin MB, Imhof BA, Dejana E, Engelhardt B, Nourshargh S.
  Endothelial cell activation leads to neutrophil transmigration as supported by the sequential roles of ICAM-2, JAM-A and PECAM-1.
  Blood. 2009, Jun 11;113(24); 6246-57. IF: 10,432
• Blasi F, Sidenius N.
  Efferocytosis: another function of uPAR.
  Blood. 2009, Jul 23;114(4); 752-3. IF: 10,432
• De Cecco L, Musella V, Veneroni S, Cappelletti V, Bongarzone I, Callari M, Valeri B, Pierotti MA, Daidone MG.
  Impact of biospecimens handling on biomarker research in breast cancer.
  BMC Cancer. 2009, Nov 24;9; 409. IF: 3,087
• Sinilnikova OM, Antoniou AC, Simard J, Healey S, Léoné M, Sinnett D, Spurdle AB, Beesley J, Chen X; kConFab, Greene MH, Loud JT, Lejbkowicz F, Rennert G, Dishon S, Andrulis IL; OCGN, Domchek SM, Nathanson KL, Manoukian S, Radice P, Konstantopoulou I, Blanco I, Laborde AL, Durán M, Osorio A, Benitez J, Hamann U, Hogervorst FB, van Os TA, Gille HJ; HEBON, Peock S, Cook M, Luccarini C, Evans DG, Lalloo F, Eeles R, Pichert G, Davidson R, Cole T, Cook J, Paterson J, Brewer C; EMBRACE, Hughes DJ, Coupier I, Giraud S, Coulet F, Colas C, Soubrier F, Rouleau E, Bièche I, Lidereau R, Demange L, Nogues C, Lynch HT; GEMO, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Sutter C, Deissler H, Schaefer D, Froster UG; GC-HBOC, Aittomäki K, Nevanlinna H, McGuffog L, Easton DF, Chenevix-Trench G, Stoppa-Lyonnet D; Consortium of Investigators of Modifiers of BRCA1/2.
  The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
  Br J Cancer. 2009, Oct 20;101(8); 1456-60. IF: 4,846
• Fernández-Ramires R, Solé X, De Cecco L, Llort G, Cazorla A, Bonifaci N, Garcia MJ, Caldés T, Blanco I, Gariboldi M, Pierotti MA, Pujana MA, Benítez J, Osorio A.
  Gene expression profiling integrated into network modelling reveals heterogeneity in the mechanisms of BRCA1 tumorigenesis.
  Br J Cancer. 2009, Oct 20;101(8), 1469-80. IF: 4,846
• Tomlinson IP, Dunlop M, Campbell H, Zanke B, Gallinger S, Hudson T, Koessler T, Pharoah PD, Niittymäkix I, Tuupanenx S, Aaltonen LA, Hemminki K, Lindblom A, Försti A, Sieber O, Lipton L, van Wezel T, Morreau H, Wijnen JT, Devilee P, Matsuda K, Nakamura Y,
  COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer.
  Br J Cancer. 2009, Nov 17 (in press). IF: 4,846.
• Osorio A, Milne RL, Pita G, Peterlongo P, Heikkinen T, Simard J, Chenevix-Trench G, Spurdle AB, Beesley J, Chen X, Healey S; KConFab, Neuhausen SL, Ding YC, Couch FJ, Wang X, Lindor N, Manoukian S, Barile M, Viel A, Tizzoni L, Szabo CI, Foretova L, Zikan
  Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA). Br J Cancer. 2009, Dec 15;101(12); 2048-54. IF: 4,846
• Jakubowska A, Rozkrut D, Antoniou A, Hamann U, Lubinski J, on behalf of CIMBA, the Consortium of Investigators of Modifiers of BRCA1/2-Related Cancer: kConFab, UCI, MAYO, MBCSG, ModSqad, NCI, NICCC, OCGN, OUH, PBCS, SMC, SWE-BRCA, UPENN, IHCC, CNIO, DKFZ, HEBON, EMBRACE, FCCC, GEMO, Breast Cancer Family Registry, MUV, CBCS, MSKCC, GOG, OSU CCG, UTBCS, GC-HBOC, HCSC, HEBCS, INHERIT BRCAs. Other CIMBA contributing members were acknowledged as follow: kConFab: Chenevix-Trench G, Spurdle AB, Healey S, Chen X, Beesley J and kConFab Investigators; UCI: Neuhausen SL, Ding YC; MAYO: Couch FJ, Wang X, Karaus M; MBCSG: Peterlongo P, Manoukian S, Peissel B, Bonanni B, Viel A, Radice P; ModSqad: Szabo CI, Foretova L, Zikan M, Poppe B; NCI: Mai PL, Greene MH; NICCC: Lejbkowicz F, Rennert G; OCGN: Andrulis IL, Ozcelik H, Glendon G; OUH: Thomassen M, Gerdes AM, Kruse TA; PBCS: Caligo MA, Lombardi G; SMC: Laitman Y, Kaufman B, Milgrom R, Cohen S, Gershoni-Baruch R, Dragan E, Friedman E; SWE-BRCA: Loman N, Karlsson P, Ehrencrona H, von Wachenfeldt A; UPENN: D’Andrea K, Domchek SM, Nathanson KL, Rebbeck TR; IHCC: Serrano P, Cybulski C, Debniak T, Górski B, Byrski T, Huzarski T, Gronwald J; CNIO: Osorio A, Yannoukakos D, Cusido M, Benítez J; DKFZ: Dünnebier T; HEBON: Hogervorst FBL, van Leeuwen FE, Hooning MJ, van Asperen CJ, Devilee P, Ligtenberg M, van der Luijt RB, Aalfs CM, Waisfisz Q, Blok MJ; EMBRACE: Easton D, Peock S, Cook M, Oliver C, Frost D, Harrington P, Evans G, Lalloo F, Eeles R, Izatt L, Chu C, Eccles D, Douglas F, Brewer C, McGuffog L; FCCC: Godwin AK; GEMO: Sinilnikova OM, Stoppa-Lyonnet D, Mazoyer S, Bonadona V, Lasset C, Dreyfus H, Leroux D, Hardouin A, Berthet P, Noguchi T, Sobol H, Rouleau E, Nogues C, Frénay M, Vénat-Bouvet L, Imyanitov E; Breast Cancer Family Registry: John EM, Buys SS, Daly M, Hopper J, Terry MB, Miron A, Yassin Y, Goldgar D; MUV: Singer CF, Gschwantler-Kaulich D, Pfeiler G, Dressler C; CBCS: Hansen TVO, ILUH: Agnarsson BA; MSKCC: Kirchhoff T, Pal P, Offit K; GOG: Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV; OSU CCG: Ewart Toland A; UTBCS: Allavena A; GC-HBOC: Versmold B, Wappenschmidt B, Engel C, Meindl A, Engert S, Arnold N, Fiebig B, Weber BHF, Niederacher D, Deissler H, Sutter C, Kast K, Preisler-Adams S; HCSC: Caldes T, de la Hoya M; HEBCS: Nevanlinna H, Aittomäki K; INHERIT BRCAs: Simard J, Song H.
  The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: Results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers
  Breast Cancer Res Treat. 2009, Oct 30.in press. IF: 5,684
• De Vecchi G, Verderio P, Pizzamiglio S, Manoukian S, Barile M, Fortuzzi S, Ravagnani F, Pierotti MA, Radice P, Peterlongo P.
  Evidences for association of the CASP8 -652 6N del promoter polymorphism with age at diagnosis in familial breast cancer cases.
  Breast Cancer Res Treat. 2009, Feb;113(3); 607-8. IF: 5,684
• Antoniou AC, Rookus M, Andrieu N, Brohet R, Chang-Claude J, Peock S, Cook M, Evans DG, Eeles R; EMBRACE, Nogues C, Faivre L, Gesta P; GENEPSO, van Leeuwen FE, Ausems MG, Osorio A; GEO-HEBON, Caldes T, Simard J, Lubinski J, Gerdes AM, Olah E, Fürhauser C, Olsson H, Arver B, Radice P, Easton DF, Goldgar DE.
  Reproductive and Hormonal Factors, and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Results from the International BRCA1/2 Carrier Cohort Study.
  Cancer Epidemiol Biomarkers. 2009, Feb;18(2); 601-10. IF: 4,770
• Gerbino E, Tapinassi C, Malazzi O, Micucci C, Calasanz MJ, Beltran-Heredia JM, Gasparini P, Odero MD, Pelicci PG, Belloni E.
  A novel t(7;13)(p12;q33 approximately q34) in AML-M2.
  Cancer Genet Cytogenet. 2009, Dec;195(2); 198-200. IF: 1,482
• Ciró M, Prosperini E, Quarto M, Grazini U, Walfridsson J, McBlane F, Nuciforo P, Pacchiana G, Capra M, Christensen J, Helin K
  ATAD2 Is a Novel Cofactor for MYC, Overexpressed and Amplified in Aggressive Tumors.
  Cancer Res. 2009, Nov 1;69(21); 8491-8. IF: 7,514
• Sartore-Bianchi A, Martini M, Molinari F, Veronese S, Nichelatti M, Artale S, Di Nicolantonio F, Saletti P, De Dosso S, Mazzucchelli L, Frattini M, Siena S, Bardelli A.
  PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies.
  Cancer Res. 2009, Mar 1;69(5); 1851-7. IF: 7,514
• Demoe JH, Santaguida S, Daum JR, Musacchio A*, Gorbsky GJ.
  A High Throughput, Whole Cell Screen for Small Molecule Inhibitors of the Mitotic Spindle Checkpoint Identifies OM137, a Novel Aurora Kinase Inhibitor. Cancer Res. 2009, Feb 15;69(4); 1509-16. IF: 7,514
• Catucci I, Verderio P, Pizzamiglio S, Manoukian S, Peissel B, Barile M, Tizzoni L, Bernard L, Ravagnani F, Galastri L, Pierotti MA, Radice P, Peterlongo P.
  Letter to the Editor: SNPs in ultraconserved elements and familial breast cancer risk.
  Carcinogenesis. 2009, Mar;30(3); 544-5. IF: 4,930
• Weiss SM, Ladwein M, Schmidt D, Ehinger J, Lommel S, Städing K, Beutling U, Disanza A, Frank R, Jänsch L, Scita G, Gunzer F, Rottner K, Stradal TE.
  IRSp53 links the enterohemorrhagic E. coli effectors Tir and EspFU for actin pedestal formation. Cell Host Microbe. 2009, Mar 19;5(3); 244-58. IF: 7,436
• Hu J, Troglio F, Mukhopadhyay A, Everingham S, Kwok E, Scita G, Craig AW.
  F-BAR-containing adaptor CIP4 localizes to early endosomes and regulates Epidermal Growth Factor Receptor trafficking and downregulation
  Cell Signal. 2009, Nov;21(11); 1686-97. IF: 4,305
• Dejana E, Orsenigo F, Molendini C, Baluk P, McDonald DM
  Organization and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees.
  Cell Tissue Res. 2009, Jan;335(1); 17-25. IF: 2,740
• Dejana E, Simionescu M, Wolburg H.
  Endothelial cell biology and pathology.
  Cell Tissue Res. 2009, Jan;335(1); 1-3. IF: 2,740
• Mazzone M, Dettori D, Leite de Oliveira R, Loges S, Schmidt T, Jonckx B, Tian YM, Lanahan AA, Pollard P, Ruiz de Almodovar C, De Smet F, Vinckier S, Aragonés J, Debackere K, Luttun A, Wyns S, Jordan B, Pisacane A, Gallez B, Lampugnani MG, Dejana E, Simons
  Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization.
  Cell. 2009, Mar 6;136(5); 839-51. IF: 31,253
• Doksani Y, Bermejo R, Fiorani S, Haber JE, Foiani M.
  Replicon Dynamics, Dormant Origin Firing, and Terminal Fork Integrity after Double-Strand Break Formation.
  Cell. 2009, Apr 17;137(2); 247-58. IF: 31,253
• Bermejo R, Capra T, Gonzalez-Huici V, Fachinetti D, Cocito A, Natoli G, Katou Y, Mori H, Kurokawa K, Shirahige K, Foiani M br> Genome-organizing factors Top2 and Hmo1 prevent chromosome fragility at sites of S phase transcription.
  Cell. 2009, Sep 4;138(5); 870-84. IF: 31,253
• Cicalese A, Bonizzi G, Pasi CE, Faretta M, Ronzoni S, Giulini B, Brisken C, Minucci S, Di Fiore PP, Pelicci PG.
  The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells
  Cell. 2009, Sep 18;138(6); 1083-95. IF: 31,253
• Mancuso P, Calleri A, Bertolini F, Tacchetti C, Heymach JV, Shalinsky DR.
  Quantification of circulating endothelial cells by flow cytometry.
  Clin Cancer Res. 2009, May 15;15(10); 3640. IF: 6,488
• Mancuso P, Antoniotti P, Quarna J, Calleri A, Rabascio C, Tacchetti C, Braidotti P, Wu HK, Zurita AJ, Saronni L, Cheng JB, Shalinsky DR, Heymach JV, Bertolini F.
  Validation of a Standardized Method for Enumerating Circulating Endothelial Cells and Progenitors: Flow Cytometry and Molecular and Ultrastructural Analyses.
  Clin Cancer Res. 2009, Jan 1;15(1) 267-273. IF: 6,488
• Aceto GM, De Lellis L, Catalano T, Veschi S, Radice P, Di Iorio A, Mariani-Costantini R, Cama A, Curia MC.
  Nonfluorescent Denaturing HPLC-Based Primer-Extension Method for Allele-Specific Expression: Application to Analysis of Mismatch Repair Genes.
  Clin Chem. 2009, Sep;55(9) 1711-8. IF: 5,579
• Abraham S, Yeo M, Montero-Balaguer M, Paterson H, Dejana E, Marshall CJ, Mavria G
  VE-Cadherin-Mediated Cell-Cell Interaction Suppresses Sprouting via Signaling to MLC2 Phosphorylation.
  Curr Biol. 2009, Apr 28;19(8): 668-74. IF: 10,777 <
• Evan GI, d'Adda di Fagagna F.
  Cellular senescence: hot or what?
  Curr Opin Genet Dev. 2009, Feb;19(1); 25-31. IF: 9,677
• Combes AN, Wilhelm D, Davidson T, Dejana E, Harley V, Sinclair A, Koopman P.
  Endothelial cell migration directs testis cord formation.
  Dev Biol. 2009, Feb 1;326(1); 112-120. IF: 4,416
• Dejana E, Tournier-Lasserve E, Weinstein BM.
  The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications.
  Dev Cell. 2009, Feb;16(2);209-21. IF: 4,416
• Strilic B, Kucera T, Eglinger J, Hughes MR, McNagny KM, Tsukita S, Dejana E, Ferrara N, Lammert E
  The molecular basis of vascular lumen formation in the developing mouse aorta.
  Dev Cell. 2009, Oct;17(4); 505-15. IF 4,416
• Ferguson, S., Raimondi, A., Paradise, S., Shen, H., Mesaki, K., Ferguson, A., Destaing, O., Ko, G., Takasaki, J., Cremona O., O' Toole, E., De Camilli, P
  Coordinated Actions of Actin and BAR Proteins Upstream of Dynamin at Endocytic Clathrin-Coated Pits.
  Dev. Cell 2009, Volume 17, Issue 6, 811-822. IF; 4,416
• Hosking B, François M, Wilhelm D, Orsenigo F, Caprini A, Svingen T, Tutt D, Davidson T, Browne C, Dejana E, Koopman P.
  Sox7 and Sox17 are strain-specific modifiers of the lymphangiogenic defects caused by Sox18 dysfunction in mice.
  Development. 2009, Jul;136(14); 2385-91. IF: 6,812
• Chauhan BK, Disanza A, Choi SY, Faber SC, Lou M, Beggs HE, Scita G, Zheng Y, Lang RA.
  Cdc42- and IRSp53-dependent contractile filopodia tether presumptive lens and retina to coordinate epithelial invagination.
  Development. 2009, Nov;136(21); 3657-67. IF: 6,812
• Santoriello C, Deflorian G, Pezzimenti F, Kawakami K, Lanfrancone L, d'Adda di Fagagna F, Mione M.
  Expression of H-RASV12 in a zebrafish model of Costello syndrome causes cellular senescence in adult proliferating cells.
  Dis Model Mech. 2009, Jan;2(1-2); 56-67 NO IF
• Branzei D, Foiani M. The checkpoint response to replication stress.
  DNA Repair (Amst). 2009, Sep 2;8(9); 1038-46. IF: 5,095
• Bernstein KA, Shor E, Sunjevaric I, Fumasoni M, Burgess RC, Foiani M, Branzei D, Rothstein R.
  Sgs1 function in the repair of DNA replication intermediates is separable from its role in homologous recombinational repair.
  EMBO J. 2009, Apr 8;28(7); 915-25. IF: 8,295
• Ciliberto A, Shah JV.
  A quantitative systems view of the spindle assembly checkpoint.
  EMBO J. 2009, Jul 23;28(15); 2162-2173. IF: 8,295
• De Santa F, Narang V, Yap ZH, Tusi BK, Burgold T, Austenaa L, Bucci G, Caganova M, Notarbartolo S, Casola S, Testa G, Sung WK, Wei CL, Natoli G.
  Jmjd3 contributes to the control of gene expression in LPS-activated macrophages
  EMBO J. 2009, Nov 4;28(21); 3341-52. IF: 8,295
• Palamidessi A, Testa I, Frittoli E, Barozzi S, Garrè M, Mazza D, Di Fiore PP, Diaspro A, Scita G, Faretta M.
  Understanding biological dynamics: following cells and molecules to track functions and mechanisms.
  Eur Biophys J. 2009, May 20. 0175-7571 (Print) 1432-1017 (Online). IF: 2,409
• Chiappetta G, Ottaiano A, Vuttariello E, Monaco M, Galdiero F, Gallipoli A, Pilotti S, Jodice G, Siranoush M, Colombo M, Ripamonti CB, Pallante PL, Radice P, Fusco A.
  HMGA1 protein expression in familial breast carcinoma patients.
  Eur J Cancer 2009, Nov-05. IF: 4,475
• Acconcia F, Sigismund S, Polo S.
  Ubiquitin in trafficking: The network at work. Exp Cell Res 2009, May 15;315(9); 1610-8. IF: 3,224
• Verhoef LG, Heinen C, Selivanova A, Halff EF, Salomons FA, Dantuma NP.
  Minimal length requirement for proteasomal degradation of ubiquitin-dependent substrates.
  FASEB J. 2009, Jan;23(1); 123-33. IF: 7,049
• Tosoni D, Cestra G.
  CAP (Cbl associated protein) regulates receptor-mediated endocytosis.
  FEBS Lett. 2009, Jan 22;583(2); 293-300. IF: 3,264
• Blasi F, Sidenius N.
  The urokinase receptor: focused cell surface proteolysis, cell adhesion and signaling.
  FEBS Lett. 2009, Dec 27 (in press). IF: 3,264
• G. Boniolo, R. Faraldo, A. Saggion
  On Spatial and Temporal ex mensura Boundaries
  Foundations of Science. 2009, 14(3); pp.181-193. NO IF
• Reid JF, Gariboldi M, Sokolova V, Capobianco P, Lampis A, Perrone F, Signoroni S, Costa A, Leo E, Pilotti S, Pierotti MA.
  Integrative approach for prioritizing cancer genes in sporadic colon cancer.
  Genes Chromosomes Cancer. 2009; Nov;48(11);953-62. IF 3,925
• Cunningham O, Campion S, Perry VH, Murray C, Sidenius N, Docagne F, Cunningham C.
  Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation.br> Glia. 2009; Dec;57(16);1802-14. IF 5,599
• Antoniou AC, Sinilnikova OM, McGuffog L, Healey S, Nevanlinna H, Heikkinen T, Simard J, Spurdle AB, Beesley J, Chen X; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Neuhausen SL, Ding YC, Couch FJ, Wang X, Fredericksen Z, Peterlongo P, Peissel B, Bonanni B, Viel A, Bernard L, Radice P, Szabo CI, Foretova L, Zikan M, Claes K, Greene MH, Mai PL, Rennert G, Lejbkowicz F, Andrulis IL, Ozcelik H, Glendon G; OCGN, Gerdes AM, Thomassen M, Sunde L, Caligo MA, Laitman Y, Kontorovich T, Cohen S, Kaufman B, Dagan E, Baruch RG, Friedman E, Harbst K, Barbany-Bustinza G, Rantala J, Ehrencrona H, Karlsson P, Domchek SM, Nathanson KL, Osorio A, Blanco I, Lasa A, Benítez J, Hamann U, Hogervorst FB, Rookus MA, Collee JM, Devilee P, Ligtenberg MJ, van der Luijt RB, Aalfs CM, Waisfisz Q, Wijnen J, van Roozendaal CE; HEBON, Peock S, Cook M, Frost D, Oliver C, Platte R, Evans DG, Lalloo F, Eeles R, Izatt L, Davidson R, Chu C, Eccles D, Cole T, Hodgson S; EMBRACE, Godwin AK, Stoppa-Lyonnet D, Buecher B, Léoné M, Bressac-de Paillerets B, Remenieras A, Caron O, Lenoir GM, Sevenet N, Longy M, Ferrer SF, Prieur F; GEMO, Goldgar D, Miron A, John EM, Buys SS, Daly MB, Hopper JL, Terry MB, Yassin Y; Breast Cancer Family Registry, Singer C, Gschwantler-Kaulich D, Staudigl C, Hansen TO, Barkardottir RB, Kirchhoff T, Pal P, Kosarin K, Offit K, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV, Toland AE, Montagna M, Casella C, Imyanitov EN, Allavena A, Schmutzler RK, Versmold B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Deissler H, Fiebig B, Suttner C, Schönbuchner I, Gadzicki D, Caldes T, de la Hoya M, Pooley KA, Easton DF, Chenevix-Trench G; CIMBA.
  Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.
  Hum Mol Genet. 2009; Nov 15;18(22) 4442-56. IF 7,249
• Bleeker FE, Lamba S, Rodolfo M, Scarpa A, Leenstra S, Vandertop WP, Bardelli A.
  Mutational profiling of cancer candidate genes in glioblastoma, melanoma and pancreatic carcinoma reveals a snapshot of their genomic landscapes.
  Hum Mutat. 2009; Feb;30(2),E451-9. IF 7,033.
• Bleeker FE, Lamba S, Leenstra S, Troost D, Hulsebos T, Vandertop WP, Frattini M, Molinari F, Knowles M, Cerrato A, Rodolfo M, Scarpa A, Felicioni L, Buttitta F, Malatesta S, Marchetti A, Bardelli A.
  IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors.
  Hum Mutat. 2009; Vol.30, issue 1. IF: 7,033.
• Balakrishnan A, Penachioni JY, Lamba S, Bleeker FE, Zanon C, Rodolfo M, Vallacchi V, Scarpa A, Felicioni L, Buck M, Marchetti A, Comoglio PM, Bardelli A, Tamagnone L.
  Molecular profiling of the "plexinome" in melanoma and pancreatic cancer.
  Hum Mutat. 2009; Aug;30(8); 1167-74 IF: 7,033
• Panfoli I, Calzia D, Bianchini P, Ravera S, Diaspro A, Candiano G, Bachi A, Monticone M, Aluigi MG, Barabino S, Calabria G, Rolando M, Tacchetti C, Morelli A, Pepe IM.
  Evidence for aerobic metabolism in retinal rod outer segment disks.
  Int J Biochem Cell Biol. 2009; Dec;41(12); 2555-65. IF: 4,178
• Amodio G, Renna M, Paladino S, Venturi C, Tacchetti C, Moltedo O, Franceschelli S, Mallardo M, Bonatti S, Remondelli P.
  Endoplasmic reticulum stress reduces the export from the ER and alters the architecture of post-ER compartments.
  Int J Biochem Cell Biol. 2009. Dec;41(12): 2511-21; IF: 4,178.
• Paradiso A, Mangia A, Orlando C, Verderio P, Belfiglio M, Marchetti A, Bertario L, Chiappetta G, Gion M, Tonini GP, Podo F, Vocaturo A, Silvestrini R, Romani M, Belloni E, Cavallo D, Ulivi P, Tommasi S, Steffan A, Russo A, Alessio M, Calistri D, Zancan M.
  The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysis.
  Int J Biol Markers. 2009; Jul-Sep;24(3) 119-29. IF: 1,265
• Monti L, Cinquetti R, Guffanti A, Nicassio F, Cremona M, Lavorgna G, Bianchi F, Vignati F, Cittaro D, Taramelli R, Acquati F.
  In silico prediction and experimental validation of natural antisense transcripts in two cancer-associated regions of human chromosome 6.
  Int J Oncol. 2009; Apr;34(4),1099-108. IF: 2,234.
• Valdagni R, Rancati T, Ghilotti M, Cozzarini C, Vavassori V, Fellin G, Fiorino C, Girelli G, Barra S, Zaffaroni N, Pierotti MA, Gariboldi M.
  To Bleed or Not to Bleed. A Prediction Based on Individual Gene Profiling Combined With Dose-Volume Histogram Shapes in Prostate Cancer Patients Undergoing Three-Dimensional Conformal Radiation Therapy.
  Int J Radiat Oncol Biol Phys. 2009; Aug 1;74(5) 1431-40. IF: 4,639
• Milanese M, Bonifacino T, Zappettini S, Usai C, Tacchetti C, Nobile M, Bonanno G.
  Glutamate Release from Astrocytic Gliosomes under Physiological and Pathological Conditions.
  Int Rev Neurobiol. 2009 85:295-318. IF: 2,476
• Yamada H, Padilla-Parra S, Park SJ, Itoh T, Chaineau M, Monaldi I, Cremona O, Benfenati F, De Camilli P, Coppey-Moisan M, Tramier M, Galli T, Takei K.
  Dynamic interaction of amphiphysin with N-WASP regulates actin assembly. J Biol Chem. 2009; Dec 4;284(49); 34244-56. IF: 5,520
• Sawallisch C, Berhörster K, Disanza A, Mantoani S, Kintscher M, Stoenica L, Dityatev A, Sieber S, Kindler S, Morellini F, Schweizer M, Boeckers TM, Korte M, Scita G, Kreienkamp HJ.
  The insulin receptor substrate of 53 kDa (IRSp53) limits hippocampal synaptic plasticity.
  J Biol Chem. 2009. Apr 3;284(14); 9225-9236. IF: 5,520.
• Balconi G, Lehmann R, Fiordaliso F, Assmus B, Dimmeler S, Sarto P, Carbonieri E, Gualco A, Campana C, Angelici L, Masson S, Mohammed SA, Dejana E, Gorini M, Zeiher AM, Latini R; GISSI-HF Investigators.
  Levels of circulating pro-angiogenic cells predict cardiovascular outcomes in patients with chronic heart failure.
  J Card Fail. 2009; Nov;15(9); 747-55. IF: 3,691
• Chiara Francavilla, Paola Cattaneo, Vladimir Berezin, Elisabeth Bock, Diletta Ami, Ario de Marco, Gerhard Christofori, and Ugo Cavallaro
  The binding of NCAM to FGFR1 induces a specific cellular response mediated by receptor trafficking.
  J Cell Biol. 187(7); 1101-1116. IF: 9,120.
• Cera MR, Fabbri M, Molendini C, Corada M, Orsenigo F, Rehberg M, Reichel CA, Krombach F, Pardi R, Dejana E. JAM-A promotes neutrophil chemotaxis by controlling integrin internalization and recycling. J Cell Sci. 2009; Jan 15;122 (Pt 2); 268-77. IF: 6,247
• Vaccari T, Rusten TE, Menut L, Nezis IP, Brech A, Stenmark H, Bilder D.br> Comparative analysis of ESCRT-I, ESCRT-II and ESCRT-III function in Drosophila by efficient isolation of ESCRT mutants.
  J Cell Sci. 2009; Jul 15;122(Pt 14); 2413-23. IF: 6,247
• Tjwa M, Sidenius N, Moura R, Jansen S, Theunissen K, Andolfo A, De Mol M, Dewerchin M, Moons L, Blasi F, Verfaillie C, Carmeliet P.
  Membrane-anchored uPAR regulates the proliferation, marrow pool size, engraftment, and mobilization of mouse hematopoietic stem/progenitor cells.
  J Clin Invest. 2009; Apr;119(4); 1008-18. IF: 16,559.
• Hikida M, Casola S, Takahashi N, Kaji T, Takemori T, Rajewsky K, Kurosaki T.
  PLC-gamma2 is essential for formation and maintenance of memory B cells.
  J Exp Med. 2009; Mar 16;206(3); 681-9. IF: 15,219
• Maddaluno L, Verbrugge SE, Martinoli C, Matteoli G, Chiavelli A, Zeng Y, Williams ED, Rescigno M, Cavallaro U.
  The adhesion molecule L1 regulates transendothelial migration and trafficking of dendritic cells.
  J Exp Med. 2009; Mar 16;206(3); 623-35. IF: 15,219.
• Cortese K, Diaspro A, Tacchetti C
  Advanced Correlative Light/Electron Microscopy: Current Methods and New Developments Using Tokuyasu Cryosections.
  J Histochem Cytochem. 2009; Dec;57(12); 1103-12. IF: 2,823
• Deflorian G, Cinquanta M, Beretta C, Venuto A, Santoriello C, Baldessari D, Pezzimenti F, Aliprandi M, Mione M, de Marco A.
  Monoclonal antibodies isolated by large-scale screening are suitable for labeling adult zebrafish (Danio rerio) tissues and cell structures.
  J Immunol Methods. 2009; Jul 31;346 (1-2); 9-17. IF: 2,120
• Siena S, Sartore-Bianchi A, Di Nicolantonio F, Balfour J, Bardelli A.
  Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor-Targeted Therapy in Metastatic Colorectal Cancer.
  J Natl Cancer Inst. 2009; Oct 7;101(19); 1308-24. IF: 14,933.
• Nebuloni M, Cinque P, Sidenius N, Ferri A, Lauri E, Omodeo-Zorini E, Zerbi P, Vago L.
  Expression of the urokinase plasminogen activator receptor (uPAR) and its ligand (uPA) in brain tissues of human immunodeficiency virus patients with opportunistic cerebral diseases.
  J Neurovirol. 2009; Jan;15(1).;99-107. IF: 1,943
• Bermejo R, Katou YM, Shirahige K, Foiani M. ChIP-on-Chip Analysis of DNA Topoisomerases.
  Methods Mol Biol. 2009; 582; 103-18. (NO IF)
• Pozzebon M, Segré CV, Chiocca S.
  Inhibition of the SUMO pathway by Gam1.
  Methods Mol Biol. 2009; 497; 285-301 (NO IF)
• Vicidomini G, Gagliani MC, Cortese K, Krieger J, Buescher P, Bianchini P, Boccacci P, Tacchetti C, Diaspro A.
  A novel approach for correlative light electron microscopy analysis.
  Microsc Res Tech. 2009; Sep 1. IF: 1,883.
• Sollier J, Driscoll R, Castellucci F, Foiani M, Jackson SP, Branzei D.
  The S. cerevisiae Esc2 and Smc5-6 Proteins Promote Sister Chromatid Junction Mediated Intra-S Repair.
  Mol Biol Cell. Mar;20(6); 1671-82. IF: 5,558.
• Ferrai C, Naum-Onganía G, Longobardi E, Palazzolo M, Disanza A, Diaz VM, Crippa MP, Scita G, Blasi F.
  Induction of HoxB Transcription by Retinoic Acid Requires Actin Polymerization.
  Mol Biol Cell. 2009; Aug;20(15); 3543-51. IF: 5,558.
• Lai FP, Szczodrak M, Oelkers JM, Ladwein M, Acconcia F, Benesch S, Auinger S, Faix J, Small JV, Polo S, Stradal TE, Rottner K.
  Cortactin Promotes Migration and PDGF-induced Actin Reorganization by Signaling to Rho-GTPases.
  Mol Biol Cell. 2009; Jul;20(14); 3209-23 IF: 5,558.
• Faurë A, Naldi A, Lopez F, Chaouiya C, Ciliberto A, Thieffry D.
  Modular logical modelling of the budding yeast cell cycle.
  Mol Biosyst. 2009; Dec;5(12):1787-96. IF: 4,236.
• Micali N, Ferrai C, Fernandez-Diaz LC, Blasi F, Crippa MP.
  Prep1 directly regulates the intrinsic apoptotic pathway by controlling Bcl-XL levels.
  Mol Cell Biol. 2009; Mar;29(5); 1143-51. IF: 5,942.
• Matafora V, D'Amato A, Mori S, Blasi F, Bachi A.
  Proteomic analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition.
  Mol Cell Proteomics. 2009; Oct;8(10); 2243-55. IF: 8,834.
• Disanza A, Frittoli E, Palamidessi A, Scita G.
  Endocytosis and spatial restriction of cell signaling.
  Mol Oncol. 2009; Aug;3(4); 280-96. (NO IF).
• Di Fiore PP.
  Endocytosis, signaling and cancer, much more than meets the eye. Mol Oncol. 2009; Aug;3(4); 273-9. (NO IF)
• Vaccari T , Bilder D.
  At the crossroads of polarity, proliferation and apoptosis: The use of Drosophila to unravel the multifaceted role of endocytosis in tumor suppression.
  Mol Oncol. 2009. Aug;3(4); 354-65. (NO IF)
• Carvalho M, Pino MA, Karchin R, Beddor J, Godinho-Netto M, Mesquita RD, Rodarte RS, Vaz DC, Monteiro VA, Manoukian S, Colombo M, Ripamonti CB, Rosenquist R, Suthers G, Borg A, Radice P, Grist SA, Monteiro AN, Billack B.
  Analysis of a set of missense, frameshift, and in-frame deletion variants of BRCA1.
  Mutat Res (FUND MOL M). 2009; Jan 15;660(1-2); 1-11. (NO IF)
• Fumagalli M, d'Adda di Fagagna F.
  SASPense and DDRama in cancer and ageing.
  Nat Cell Biol. 2009; Aug;11(8) 921-3. IF: 17,774.
• Rustighi A, Tiberi L, Soldano A, Napoli M, Nuciforo P, Rosato A, Kaplan F, Capobianco A, Pece S, Di Fiore PP, Del Sal G.
  The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer.
  Nat Cell Biol. 2009; Feb;11(2); 133-42. IF: 17,774.
• Classen AK, Bunker BD, Harvey KF, Vaccari T, Bilder D.
  A tumor suppressor activity of Drosophila Polycomb genes mediated by JAK-STAT signaling.
  Nat Genet. 2009; Oct;41(10); 1150-5. IF: 30,259.
• Kerrest A, Anand RP, Sundararajan R, Bermejo R, Liberi G, Dujon B, Freudenreich CH, Richard GF.
  RS2 and SGS1 prevent chromosomal breaks and stabilize triplet repeats by restraining recombin.
  Nat Struct Mol Biol. 2009; Feb;16(2);159-67. IF: 10,987.
• Heinrich C, Keller C, Boulay A, Vecchi M, Bianchi M, Sack R, Lienhard S, Duss S, Hofsteenge J, Hynes NE.
  Copine-III interacts with ErbB2 and promotes tumor cell migration.
  Oncogene. 2009; 14 December 2009;Epub ahead of print] IF: 7,216.
• Confalonieri S, Quarto M, Goisis G, Nuciforo P, Donzelli M, Jodice G, Pelosi G, Viale G, Pece S, Di Fiore PP.
  Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor.
  Oncogene. 2009; Aug 20;28(33); 2959-68. IF: 7,216.
• Ronzitti E, Vicidomini G, Caorsi V, Diaspro A.
  Annular pupil filter under shot-noise condition for linear and non linear microscopy.
  Opt Express. 2009; Apr 13;17(8); 6867-80. IF: 3,880.
• Terenziani M, Sardella M, Gamba B, Testi MA, Spreafico F, Ardissino G, Fedeli F, Fossati-Bellani F, Radice P, Perotti D.
  A novel WT1 mutation in a 46,XY boy with congenital bilateral cryptorchidism, nystagmus and Wilms tumor.
  Pediatr Nephrol. 2009; Jul;24(7); 1413-7. IF: 2,321.
• Simonetta M, Manzoni R, Mosca R, Mapelli M, Massimiliano L, Vink M, Novak B, Musacchio A, Ciliberto A.
  The influence of catalysis on mad2 activation dynamics.
  PLoS Biol. 2009; Jan 13;7(1); e10. IF: 12,683.
• Menna E, Disanza A, Cagnoli C, Schenk U, Gelsomino G, Frittoli E, Hertzog M, Offenhauser N, Sawallisch C, Kreienkamp HJ, Gertler FB, Di Fiore PP, Scita G, Matteoli M.
  Eps8 regulates axonal filopodia in hippocampal neurons in response to brain-derived neurotrophic factor (BDNF).
  PLoS Biol. 2009; Jun 30;7(6); e1000138. IF: 12,683.
• Giuliani C, Troglio F, Bai Z, Patel FB, Zucconi A, Malabarba MG, Disanza A, Stradal TB, Cassata G, Confalonieri S, Hardin JD, Soto MC, Grant BD, Scita G.
  Requirements for F-BAR proteins TOCA-1 and TOCA-2 in actin dynamics and membrane trafficking during Caenorhabditis elegans oocyte growth and embryonic epidermal morphogenesis.
  PLoS Genet. 2009; Oct;5(10); e1000675. IF: 8,883.
• Meani N, Pezzimenti F, Deflorian G, Mione M, Alcalay M
  The tumor suppressor PRDM5 regulates Wnt signaling at early stages of zebrafish development.
  PLoS ONE. 2009; 4(1); e4273. (NO IF)
• Villaescusa JC, Buratti C, Penkov D, Mathiasen L, Planagumà J, Ferretti E, Blasi F.
  Cytoplasmic Prep1 interacts with 4EHP inhibiting Hoxb4 translation.
  PLoS ONE. 2009; 4(4); e5213 (NO IF)
• Sirchia SM, Tabano S, Monti L, Recalcati MP, Gariboldi M, Grati FR, Porta G, Finelli P, Radice P, Miozzo M.
  Misbehaviour of XIST RNA in Breast Cancer Cells.
  PLoS ONE. 2009; 4(5); e5559. (NO IF)
• Bleeker FE, Lamba S, Zanon C, van Tilborg AA, Leenstra S, Troost D, Hulsebos T, Vandertop WP, Bardelli A.
  Absence of AKT1 mutations in glioblastoma.
  PLoS ONE. 2009; May 20;4(5); e5638. (NO IF).
• Sarnataro D, Caputo A, Casanova P, Puri C, Paladino S, Tivodar SS, Campana V, Tacchetti C, Zurzolo C.
  Lipid rafts and clathrin cooperate in the internalization of PrP in epithelial FRT cells
  PLoS One. 2009; Jun 8;4(6); e5829. (NO IF)
• Yang C, Hoelzle M, Disanza A, Scita G, Svitkina T.
  Coordination of membrane and actin cytoskeleton dynamics during filopodia protrusion.
  PLoS One. 2009; May 25;4(5). e5678. (NO IF).
• Sartore-Bianchi A, Di Nicolantonio F, Nichelatti M, Molinari F, De Dosso S, Saletti P, Martini M, Cipani T, Marrapese G, Mazzucchelli L, Lamba S, Veronese S, Frattini M, Bardelli A, Siena S.
  Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer.
  PLoS One. 2009; Oct 2;4(10); e7287. (NO IF)
• Felice B, Cattoglio C, Cittaro D, Testa A, Miccio A, Ferrari G, Luzi L, Recchia A, Mavilio F.
  Transcription factor binding sites are genetic determinants of retroviral integration in the human genome.
  PLoS ONE. 2009; 4(2); e4571ì. (NO IF)
• Lamba S, Felicioni L, Buttitta F, Bleeker FE, Malatesta S, Corbo V, Scarpa A, Rodolfo M, Knowles M, Frattini M, Marchetti A, Bardelli A.
  Mutational profile of GNAQQ209 in human tumors
  PLoS One. 2009; Aug 31;4(8); e6833. (NO IF)
• Montero-Balaguer M, Swirsding K, Orsenigo F, Cotelli F, Mione M, Dejana E.
  Stable vascular connections and remodeling require full expression of VE-cadherin in zebrafish embryos.
  PLoS One. 2009; Jun 3;4(6); e5772. (NO IF).
• Westhoff B, Colaluca IN, D'Ario G, Donzelli M, Tosoni D, Volorio S, Pelosi G, Spaggiari L, Mazzarol G, Viale G, Pece S, Di Fiore PP.
  Alterations of the Notch pathway in lung cancer.
  Proc Natl Acad Sci U S A. 2009; Dec. 29, 2009 ,vol. 106 no. 52; 22293-22298. IF: 9,380.
• Villa F, Capasso P, Tortorici M, Forneris F, de Marco A, Mattevi A, Musacchio A*.
  Crystal structure of the catalytic domain of Haspin, an atypical kinase implicated in chromatin organization.
  Proc Natl Acad Sci U S A. 2009; Dec 1;106(48); 20204-9. IF: 9,380
• Chen H, Ko G, Zatti A, Di Giacomo G, Liu L, Raiteri E, Perucco E, Collesi C, Min W, Zeiss C, De Camilli P, Cremona O.
  Embryonic arrest at midgestation and disruption of Notch signaling produced by the absence of both epsin 1 and epsin 2 in mice.
  Proc Natl Acad Sci U S A.; Aug 18;106(33); 13838-43. IF: 9,380.
• Chen YH, Choi K, Szakal B, Arenz J, Duan X, Ye H, Branzei D, Zhao X.
  Interplay between the Smc5/6 complex and the Mph1 helicase in recombinational repair.
  Proc Natl Acad Sci U S A. 2009; Dec 15;106(50); 21252-21257. IF: 9,380.
• Monegal A, Ami D, Martinelli C, Huang H, Aliprandi M, Capasso P, Francavilla C, Ossolengo G, de Marco A.
  Immunological applications of single-domain llama recombinant antibodies isolated from a naive library.
  Protein Eng Des Sel. 2009 ; Apr;22(4); 273-80. IF: 2,787
• Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, Burchfield J, Fox H, Doebele C, Ohtani K, Chavakis E, Potente M, Tjwa M, Urbich C, Zeiher AM, Dimmeler S.
  MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice
  Science. 2009; Jun 26;324(5935); 1710-3. IF: 28,103.
• Francavilla C, Maddaluno L, Cavallaro U.
  The functional role of cell adhesion molecules in tumor angiogenesis.
  Semin Cancer Biol. 2009; 19; 298-309. IF: 8,284.
• Sidenius, N, Blasi, F.
  Urokinase-type plasminogen activator receptor.
  UCSD-Nature Molecule Pages. 2009; 6-Nov-09. (NO IF).
• Mione M, Meijer AH, Snaar-Jagalska BE, Spaink HP, Trede N.
  Disease Modeling in Zebrafish: Cancer and Immune Responses—A Report on a Workshop Held in Spoleto, Italy, 20–22 July 2009.
  Zebrafish. 2009; Dec;6(4); 445-51. (NO IF)
• Anelli V, Santoriello C, Distel M, Koster RW, Ciccarelli F, Mione M.
  Global repression of gene expression in a zebrafish model of melanoma is linked to epigenetic regulation.
  Zebrafish. 2009; Dec;6(4); 417-24. (NO IF).

 Elenco completo delle 123 pubblicazioni del 2009
   (formato pdf)

 Archivio